dr. czerniecki on the benefit of tucatinib in her2 breast cancer and brain metastases
Published 3 years ago • 75 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:30
dr. czerniecki on treatment options for patients with her2 brain metastases
-
1:19
dr. czerniecki on the importance of multidisciplinary efforts for breast cancer brain/cns metastases
-
3:08
the benefits of tucatinib in her2 breast cancer
-
1:52
dr. o’shaughnessy on the utility of tucatinib in the her2 breast cancer brain metastases
-
2:15
dr. hamilton on the promise of tucatinib in her2 breast cancer brain metastases
-
3:15
a close look at tucatinib in her breast cancer
-
2:10
treating cns metastases in her2 breast cancer
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
3:45
her2climb: implications for brain metastases in her2 mbc
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:20
dr. ahmed on remaining questions with tucatinib in breast cancer brain metastases
-
5:14
her2 mbc: systemic therapies and her2climb-02 trial
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
4:30
tucatinib for the treatment of her2 breast cancer
-
1:39
dr. anders discusses the use of neratinib/capecitabine for her2-positive brain metastases
-
1:10
dr. hamilton on the fda approval of tucatinib in her2 breast cancer
-
3:35
understanding the her2climb trial
-
1:45
dr. kalinsky on neratinib and tucatinib in her2 metastatic breast cancer
-
3:21
exciting results from her2climb in her2 mbc